MedWatch

“So I called Novo Nordisk and said I wanted to work for them”

Gitte Pedersen’s career began in Novo Nordisk and the Danish drug giant led her to the US, where she is now CEO and co-founder of a diagnostics company in Manhattan – a career that is partly formed by a past peopled by engineers and women’s rights activists.

Foto: PR

Gitte Pedersen is very clear about what role her parents played in the career choices that have led to the now 50-year-old Danish engineer and CEO to an office with a view of the Manhattan skyline as the co-founder and top chief of diagnostics company Genomic Expression.

“I come from a family in which everyone on my father’s side was an engineer or an entrepreneur, so somehow it’s probably in my DNA – and my mother was a first generation women’s rights activist. So there was never any doubt that I was going for a long education; I was just not quite sure about which field to get involved in. I have always been interested in science and I grew up with discussions about the nature of black holes over the dinner table, and at some point I hear about Novo Nordisk on the television,” she tells Medwatch, adding:

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Tidligere storaktionær holder døren på klem for ny investering i Orphazyme

Venturefonden Sunstone, der for nyligt solgte ud af sine aktier i Orphazyme, afviser ikke på et senere tidspunkt igen at skyde penge i selskabet, der torsdag fik en kold skulder af FDA til selskabets NPC-kandidat. Men fondens formål gør en geninvestering til en svær øvelse, lyder det fra general partner, Sten Verland.

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier